Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies

S. Förderreuther,Qi Zhang,Virginia L. Stauffer,Sheena K. Aurora,Miguel J. A. Láinez

Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies

2018

S. Förderreuther
Qi Zhang
Virginia L. Stauffer
Sheena K. Aurora
Miguel J. A. Láinez

Background Maintenance of effect following treatment with galcanezumab compared to placebo in adult patients with episodic or chronic migraine was evaluated.

Keywords:

Placebo
Anesthesia
Migraine
Neurology
Pediatrics
Medicine
Chronic Migraine
Loading dose
Logistic regression
Subcutaneous injection
adult patients

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations